Compare · CVET vs MEDS
CVET vs MEDS
Side-by-side comparison of Covetrus Inc. (CVET) and TRxADE HEALTH Inc. (MEDS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVET and MEDS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- CVET is the larger of the two at $2.42B, about 581.7x MEDS ($4.2M).
- MEDS has hit the wire 6 times in the past 4 weeks while CVET has been quiet.
- CVET has more recent analyst coverage (8 ratings vs 1 for MEDS).
- Company
- Covetrus Inc.
- TRxADE HEALTH Inc.
- Price
- $21.00+0.24%
- $1.34-0.74%
- Market cap
- $2.42B
- $4.2M
- 1M return
- -
- -59.27%
- 1Y return
- -
- -98.45%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 6
- Recent ratings
- 8
- 1
Covetrus Inc.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
TRxADE HEALTH Inc.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Latest CVET
- Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer
- Key Cannabis Exec Changes You Need To Know About: Leafly's New CCO, Glass House's New Appointment & More
- SEC Form 15-12G filed by Covetrus Inc.
- Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600
- Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Coventrus In S&P SmallCap 600
- SEC Form SC 13D/A filed by Covetrus Inc. (Amendment)
- SEC Form 4: Cd&R Investment Associates Ix, Ltd. disposed of 33,670,541 shares
- SEC Form S-8 POS filed by Covetrus Inc.
- SEC Form SC 13E3/A filed by Covetrus Inc. (Amendment)
- Covetrus Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
Latest MEDS
- DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
- DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026
- DataMeds AI Provides Update on Corexa Health's Pharmacy Division
- DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division
- DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
- DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
- DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
- DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
- Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI
- DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders